𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A controlled clinical study of Kanjang mixture in the treatment of uncomplicated upper respiratory tract infections

✍ Scribed by Erling Thom; Terje Wollan


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
87 KB
Volume
11
Category
Article
ISSN
0951-418X

No coin nor oath required. For personal study only.

✦ Synopsis


A randomized, double-blind placebo-controlled parallel group clinical trial was performed to investigate the therapeutic effect of Kanjang mixture in the treatment of uncomplicated upper respiratory tract infections (common cold). Sixty-six patients aged between 18 and 40 years participated. Medication was taken three times daily for a minimum of 5 days or a maximum of 10 days.

The primary outcome measures were: the effect on coughing; quality of sleep; mucus discharge in the respiratory tract; nasal congestion; and a global evaluation of the clinical situation and medication tolerability. Assessments were recorded by patients using visual analogue scales 2, 4 and 10 days after the start of treatment.

Sixty patients completed the study according to the protocol. The improvement in symptoms following treatment with Kanjang mixture was significantly better on the day 2 and 4 assessments compared with placebo, while the day 10 scores were not significantly different.

Tolerability of both treatments was excellent and no side-effects were reported in either of the two groups. Treatment with the herbal mixture Kangjang significantly eased the symptoms related to uncomplicated upper respiratory tract infections. Combined with the excellent tolerability, Kanjang mixture can be an attractive alternative for the treatment of such ailments.


πŸ“œ SIMILAR VOLUMES


Is the incidence of upper respiratory tr
✍ Lynda V. Wilton; Shayne N. Freemantle; Richard Martin; Ronald D. Mann πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 111 KB πŸ‘ 1 views

In observational cohort studies which monitor drug safety, the patterns of reported events are likely to be inΒ―uenced by a number of factors. We hypothesized that the distribution of events which are unlikely to be adverse events associated with drug use, dier from that for events which may be adver